BioMendics was founded by scientists, physicians, and angel investors with a shared vision and desire to bring decades of research into small molecule liquid crystal technology out of the laboratory and into the clinic to help the people that need it most.
We are dedicated to creating safe, effective, and innovative new medications to fulfill the unmet medical needs of people with rare dermatologic disorders. Our goal is simple. To restore hope in a brighter future.
- Patient safety is at the core of every decision we make and every medication we develop.
- Our manufacturing standards must meet or exceed those outlined by the U.S. Food and Drug Administration.
- Our clinical trials are designed in consultation with experts and key opinion leaders from around the world and are performed with the utmost integrity and biomedical ethics.
- We hold our collaborators and partners to these same standards and create relationships that work for all stakeholders.
- At the end of the day, our most important goal is to deliver life-changing medications to the people that need them most.
